Carlos Alfaras | President
Mr. Alfaras has served as President of Gensco Pharma since January of 2011. Since the acquisition, the company has launched three new products based on Patented Transdermal drug delivery technology and increased revenues by 2000% under his direction.
He was immersed into generic pharmaceutical distribution as teenager helping his grandfather and father’s company National Drug Wholesale (NDW), by working entry level jobs culminating in becoming the pharmaceutical buyer by high school graduation. NDW was acquired by Harvey Labs in 1987.
He attended the University of Miami, majoring in Biology/Pre-Medical studies and utilized this education and experience to enter the pharmaceutical management world.
In his dedication for the pursuit of excellence he has had successes in creating growth in revenues at every company he has been associated with through education, team building, strategic planning and efficiently determining the development strategies for all.
He has held the following positions:
- Director of Purchasing and GM, PHARMED Group
- Vice President, Sunshine Medical
- C.O.O, DNA Pharmaceuticals
- Head of Business Development, Bioniche Pharma
- Senior Director Alternate Care and Business Development, ANDA Pharmaceuticals/ANDRX Corporation
- Executive Director, Business Strategy, ANDA/Watson Pharmaceuticals
- President & CEO, AHP Group
- President, Gensco Pharma
Mr. Alfaras currently resides on the Board of Directors for the following companies:
- AHP Group
- FDA Consulting Group
He is also a member of the following non-profit organizations:
- Catholic Charities
- I9 Sports
- Special Olympics International
Carlos Alfaras is dedicated to building a legacy of mentorship both professionally and personally and has been recognized as such by developing an ever-growing list of successful persons in the industry.
- Gensco® Pharma Partners with IntelGenx to Market RIZAPORT® in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in more...
- AAP Issues Flu Vaccine Recommendations for 2018-2019 September 6, 2018 Articles, Industry - All children should receive the flu shot as soon as it is available: AAP [To more...
- A Case Study of Treatment of Recalcitrant Nonpressure Chronic Ulcers Using Astero Gel Topical Hydrogel with 4% Lidocaine for Autolytic Debridement and Pain Management November 13, 2017 Articles, Clinical, Featured, Research -
- An Exploratory, Single-blind Study to Evaluate Both the Onset of Anesthesia of LiDORx® in Patients Aged 18–88 Years November 9, 2017 Clinical, Research -